Alamar Biosciences Inc.
ALMR | NASDAQ
$29.15
-$1.45 (-4.74%)
Nov 2, 2026, 2:30 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Revenue | 55.46M | 26.04M |
Cost of Revenue | 23.29M | 11.58M |
Gross Profit | 32.18M | 14.46M |
Operating Income | -25.88M | -12.35M |
Interest Income | 2.41M | 539K |
Pretax Income | -34.15M | -20.86M |
Net Income | -34.52M | -21.33M |
Selling & General & Admin | 31.22M | 13.79M |
Research & Development | 26.83M | 13.02M |
Other Expenses | n/a | n/a |
Operating Expenses | 58.05M | 26.8M |
Interest Expense | 447K | 223K |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 81.34M | 38.38M |
Income Tax Expense | 371K | 464K |
Shares Outstanding (Basic) | 58.67M | 69.31M |
Shares Outstanding (Diluted) | 58.67M | 69.31M |
EPS (Basic) | -0.53 | -0.31 |
EPS (Diluted) | -0.53 | -0.31 |
EBITDA | -32.54M | -19.47M |
EBIT | -33.71M | -20.64M |
Depreciation & Amortization | 1.17M | 1.17M |
Add to Watchlist
Select watchlists to add or remove ALMR